148 related articles for article (PubMed ID: 17058134)
1. Retrospective analysis of stage IV advanced gastric cancer treated with S-1 or other chemotherapy.
Shitara K; Ishiguro A; Munakata M; Wada R; Sakata Y
Int J Clin Oncol; 2006 Oct; 11(5):367-74. PubMed ID: 17058134
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of patients with metastatic gastric cancer after initial S-1 monotherapy.
Hosokawa A; Sugiyama T; Ohtsu A; Doi T; Hattori S; Kojima T; Yano T; Minashi K; Muto M; Yoshida S
J Gastroenterol; 2007 Jul; 42(7):533-8. PubMed ID: 17653648
[TBL] [Abstract][Full Text] [Related]
3. [The Clinical Outcome of Conversion Surgery for Unresectable Gastric Cancers in Our Institution].
Gunji H; Sakuramoto S; Aratani K; Chuman M; Wakata M; Miyawaki Y; Sato H; Okamoto K; Yamaguchi S; Koyama I
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1458-1460. PubMed ID: 29394667
[TBL] [Abstract][Full Text] [Related]
4. Survival after recurrence in patients with gastric cancer who receive S-1 adjuvant chemotherapy: exploratory analysis of the ACTS-GC trial.
Ito S; Ohashi Y; Sasako M
BMC Cancer; 2018 Apr; 18(1):449. PubMed ID: 29678146
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic factors and usefulness of chemotherapy with S-1 in patients received gastrectomy for stage IV gastric cancer].
Maehara N; Hidaka H; Nagaike K; Nakashima S; Hotokezaka M; Chijiiwa K
Gan To Kagaku Ryoho; 2009 Jul; 36(7):1111-4. PubMed ID: 19620798
[TBL] [Abstract][Full Text] [Related]
6. S-1 Adjuvant Chemotherapy Earlier After Surgery Clinically Correlates with Prognostic Factors for Advanced Gastric Cancer.
Yamamoto M; Sakaguchi Y; Kinjo N; Yamaguchi S; Egashira A; Minami K; Ikeda Y; Morita M; Toh Y; Okamura T
Ann Surg Oncol; 2016 Feb; 23(2):546-51. PubMed ID: 26442923
[TBL] [Abstract][Full Text] [Related]
7. Impact of insulin-like growth factor-1 receptor and amphiregulin expression on survival in patients with stage II/III gastric cancer enrolled in the Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer.
Ichikawa W; Terashima M; Ochiai A; Kitada K; Kurahashi I; Sakuramoto S; Katai H; Sano T; Imamura H; Sasako M
Gastric Cancer; 2017 Mar; 20(2):263-273. PubMed ID: 26884344
[TBL] [Abstract][Full Text] [Related]
8. Prognostic effects of oral anti-cancer drugs as adjuvant chemotherapy for 2 years after gastric cancer surgery.
Okuyama T; Korenaga D; Edagawa A; Itoh S; Oki E; Kawanaka H; Ikeda Y; Kakeji Y; Tateishi M; Tsujitani S; Takenaka K; Maehara Y
Surg Today; 2012 Aug; 42(8):734-40. PubMed ID: 22278622
[TBL] [Abstract][Full Text] [Related]
9. Effect of S-1 adjuvant chemotherapy on survival following recurrence and efficacy of first-line treatment in recurrent gastric cancer.
Hasegawa H; Fujitani K; Kurokawa Y; Hirao M; Nakazuru S; Mita E; Tsujinaka T
Chemotherapy; 2010; 56(6):436-43. PubMed ID: 21088394
[TBL] [Abstract][Full Text] [Related]
10. Retrospective analysis of clinical results and predictors of response in chemo-naive patients with advanced gastric cancer treated with S-1, an oral fluoropyrimidine derivative, as single-agent chemotherapy.
Yonemori K; Shimada Y; Goto A; Ura T; Arai T; Hamaguchi T; Muro K; Yamada Y; Shirao K
Gastric Cancer; 2004; 7(4):204-10. PubMed ID: 15616768
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of S-1 and cisplatin combination therapy in patients with advanced or recurrent gastric cancer.
Sakaguchi Y; Kabashima A; Okita K; Ojima Y; Yamamura S; Nishizaki T; Tashiro H; Matsusaka T
Gastric Cancer; 2005; 8(2):111-6. PubMed ID: 15864718
[TBL] [Abstract][Full Text] [Related]
12. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study.
Boku N; Yamamoto S; Fukuda H; Shirao K; Doi T; Sawaki A; Koizumi W; Saito H; Yamaguchi K; Takiuchi H; Nasu J; Ohtsu A;
Lancet Oncol; 2009 Nov; 10(11):1063-9. PubMed ID: 19818685
[TBL] [Abstract][Full Text] [Related]
13. Postoperative adjuvant chemotherapy with S-1 alters recurrence patterns and prognostic factors among patients with stage II/III gastric cancer: A propensity score matching analysis.
Kanda M; Murotani K; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Surgery; 2015 Dec; 158(6):1573-80. PubMed ID: 26120068
[TBL] [Abstract][Full Text] [Related]
14. Factors predictive of recurrence after surgery for gastric cancer followed by adjuvant S-1 chemotherapy.
Wada T; Kunisaki C; Hasegawa S; Takagawa R; Momiyama M; Kosaka T; Makino H; Ono HA; Oshima T; Akiyama H; Endo I
Anticancer Res; 2013 Apr; 33(4):1747-51. PubMed ID: 23564827
[TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy-mediated tumor regression in a patient with stage IV stomach small cell cancer].
Nagase H; Makari Y; Iijima S; Sakamoto T; Miyo M; Doi T; Hoshi M; Miyake Y; Oshima S; Ikeda K; Kurokawa E; Kikkawa N
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2381-3. PubMed ID: 23268084
[TBL] [Abstract][Full Text] [Related]
16. [S-1-based chemotherapy for unresectable advanced gastric cancer of the elderly or patients with renal dysfunction].
Fujiya K; Akiyama J; Yokota E; Asayama N; Ogami T; Nakajima R; Nishimura S; Sakurai T; Nagata N; Yokoi C; Kojima Y; Kobayakawa M; Gotoda T; Shimbo T; Uemura N
Gan To Kagaku Ryoho; 2011 Nov; 38(11):1817-20. PubMed ID: 22083189
[TBL] [Abstract][Full Text] [Related]
17. [Two cases of stage IV gastric cancer responding to chemotherapy with S-1 or UFT].
Nakamura Y; Yumiba T; Yamasaki Y; Momiyama T; Ito A; Akamaru Y; Sugimoto Y; Tamaoka N; Beppu N; Watanabe Y; Ohno K; Kasugai T
Gan To Kagaku Ryoho; 2007 Sep; 34(9):1463-6. PubMed ID: 17876147
[TBL] [Abstract][Full Text] [Related]
18. [The effectiveness of S-1 based sequential chemotherapy as second-line treatment for advanced/recurrent gastric cancer].
Sugimoto N; Narahara H; Sakai D; Yamamoto S; Fumoto S; Yagi T; Imamura F; Iishi H; Tatsuta M
Gan To Kagaku Ryoho; 2009 Mar; 36(3):417-24. PubMed ID: 19295265
[TBL] [Abstract][Full Text] [Related]
19. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of S-1 for stage IV gastric cancer].
Kanazawa Y; Furukawa K; Yamada T; Shirakawa T; Fujita I; Kato S; Yokoi K; Uchida E
Gan To Kagaku Ryoho; 2011 Oct; 38(10):1619-22. PubMed ID: 21996955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
